World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
53
Citations
12675
World Ranking
2374
National Ranking
1175

Alana L. Welm publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Alana L. Welm sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 281 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Alana L. Welm D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Alana L. Welm sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Alana L. Welm is affiliated with the University of Utah in the United States. Their research spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these areas, their work focuses strongly on Oncology, Molecular Biology, Cancer Research, Immunology, and Pulmonary and Respiratory Medicine.

Their main research topics include:

  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Advanced Breast Cancer Therapies
  • 3D Printing in Biomedical Research
  • Cancer Immunotherapy and Biomarkers

Frequent publication venues for Alana L. Welm include:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Cell
  • British Journal of Cancer
  • Nature Communications

Some of their recent papers are:

  • "The lingering mysteries of metastatic recurrence in breast cancer", 2020, British Journal of Cancer
  • "A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology", 2022, Nature Cancer
  • "An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence", 2021, Cancer Cell
  • "Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations", 2021, Cancer Cell
  • "Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts", 2021, Nature Genetics

Alana L. Welm collaborates frequently with a group of coauthors. The most frequent coauthors include:

  • Bryan E. Welm
  • Michael T. Lewis
  • Shunqiang Li
  • Sandra D. Scherer
  • Funda Meric-Bernstam

Best Publications

  • Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

    Yoko S. Derose;Guoying Wang;Yi Chun Lin;Philip S. Bernard

  • Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.

    Hsing Chen Tsai;Huili Li;Leander Van Neste;Yi Cai

  • Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.

    Conan G. Kinsey;Conan G. Kinsey;Soledad A. Camolotto;Amelie M. Boespflug;Amelie M. Boespflug;Katrin P. Guillen

  • Plasma exosome microRNAs are indicative of breast cancer

    Bethany N. Hannafon;Yvonne D. Trigoso;Cameron L. Calloway;Y. Daniel Zhao

  • C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4

    Hongmei Wang;Polina Iakova;Margie Wilde;Alana Welm

  • A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.

    Alejandra Bruna;Oscar M. Rueda;Wendy Greenwood;Ankita Sati Batra

  • The lingering mysteries of metastatic recurrence in breast cancer.

    Alessandra I. Riggio;Katherine E. Varley;Alana L. Welm

  • Understanding the Bone in Cancer Metastasis.

    Jaime Fornetti;Alana L Welm;Sheila A Stewart

  • RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1

    Nikolai A. Timchenko;Zong Jin Cai;Alana L. Welm;Sita Reddy

  • The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling

    Douglas S. Micalizzi;Kimberly L. Christensen;Paul Jedlicka;Ricardo D. Coletta;Ricardo D. Coletta

  • Cell division and cell survival in the absence of survivin

    Dun Yang;Alana Welm;J. Michael Bishop

  • Patient-derived xenograft (PDX) models in basic and translational breast cancer research

    Lacey E. Dobrolecki;Susie D. Airhart;Denis G. Alferez;Samuel Aparicio

  • CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms

    Nikolai A. Timchenko;Alana L. Welm;Xiaohui Lu;Lubov T. Timchenko

  • A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis.

    Qiyu Feng;Chengliang Zhang;David Lum;Joseph E. Druso

  • Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine.

    Yoko S. DeRose;Keith M. Gligorich;Guoying Wang;Ann Georgelas

  • Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer.

    Bryan E. Welm;Gerrit J.P. Dijkgraaf;Anita S. Bledau;Alana L. Welm

  • Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

    Liangliang Shen;Liangliang Shen;John M. O’Shea;Mohan R. Kaadige;Stéphanie Cunha

  • Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance

    Nobuaki Takahashi;Hsing Yu Chen;Isaac S. Harris;Daniel G. Stover

  • Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition

    Erica L. McCoy;Ritsuko Iwanaga;Paul Jedlicka;Nee Shamo Abbey

  • The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

    Alana L. Welm;Julie B. Sneddon;Carmen Taylor;Carmen Taylor;Dimitry S. A. Nuyten

Frequent Co-Authors

Michael T. Lewis
Michael T. Lewis Baylor College of Medicine
Carol J. Bult
Carol J. Bult European Bioinformatics Institute
Li Ding
Li Ding Washington University in St. Louis
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
James H. Doroshow
James H. Doroshow National Institutes of Health
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Steffi Oesterreich
Steffi Oesterreich University of Pittsburgh
Nikolai A. Timchenko
Nikolai A. Timchenko Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Molecular Biology can open doors to a variety of professional fields, including healthcare and research. For those interested in diversifying or expanding their qualifications, several online degree pathways in nursing and healthcare offer flexible, accredited options that can align with molecular biology expertise.

Professionals with an Associate Degree in Nursing (ADN) may consider programs such as adn to np to transition into nurse practitioner roles. Non-nurses looking to shift into advanced nursing careers can explore online msn programs for non nurses, which provide direct-entry routes to a master’s in nursing.

When comparing online nursing education, factors like cost, flexibility, and accreditation matter. For those seeking the best value nursing education online wgu offers competitive tuition and strong student outcomes.

If you already hold a Bachelor of Science in Nursing (BSN), there are bsn to msn online programs designed to make the path to advanced practice both affordable and convenient.

These related degrees expand your career options and enrich your understanding of the molecular basis of health and disease, enhancing your impact in the field.

Best Scientists Citing Alana L. Welm

Trending Scientists

Recently Published Articles